Meng-tzu L. Weng

Developing functional capsules for drug delivery in the digestive system and alcohol-induced gastric ulcer prevention using interfacial whey protein amyloid fibril/gum arabic complex coacervation.

Journal: International journal of biological macromolecules

Published: May 17, 2026

SN38 PLGA nanoparticles provide sustained antitumor efficacy and ameliorate colitis severity in a murine colitis-associated cancer model.

Journal: International journal of pharmaceutics: X

Published: January 20, 2026

Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel disease.

Journal: Intestinal research

Published: December 18, 2025

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

Journal: Journal of gastroenterology and hepatology

Published: December 13, 2025

The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 21, 2025

Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study Across Asia.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 16, 2025

Response to comment on "Pregnancy and perinatal outcomes of mothers with inflammatory bowel disease in Taiwan: A national database analysis".

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: September 26, 2025

Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity.

Journal: World journal of gastroenterology

Published: September 26, 2025

Temporal hospitalization trends for inflammatory bowel disease in Taiwan.

Journal: Intestinal research

Published: August 31, 2025

HLA-C03:04:01 and HLA-B15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.

Journal: World journal of gastroenterology

Published: July 11, 2025

Fecal leukocyte esterase levels predict endoscopic severity as an alternative biomarker in inflammatory bowel disease.

Journal: Clinical chemistry and laboratory medicine

Published: June 17, 2025

Demodicosis Mimics Acneiform Eruptions in Patients With Inflammatory Bowel Disease Receiving Upadacitinib.

Journal: The American journal of gastroenterology

Published: June 04, 2025

Developing functional capsules for drug delivery in the digestive system and alcohol-induced gastric ulcer prevention using interfacial whey protein amyloid fibril/gum arabic complex coacervation.

Developing functional capsules for drug delivery in the digestive system and alcohol-induced gastric ulcer prevention using interfacial whey protein amyloid fibril/gum arabic complex coacervation.

SN38 PLGA nanoparticles provide sustained antitumor efficacy and ameliorate colitis severity in a murine colitis-associated cancer model.

SN38 PLGA nanoparticles provide sustained antitumor efficacy and ameliorate colitis severity in a murine colitis-associated cancer model.

Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel disease.

Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel disease.

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

Asian Pacific Association of Gastroenterology (APAGE) Clinical Practice Guidelines on the Use of Small Molecules and IL-23 p19 Inhibitors in Ulcerative Colitis and Crohn's Disease.

The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma.

The addition of celecoxib enhances the therapeutic benefit of cabozantinib and anti-PD1 in hepatocellular carcinoma.

Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study Across Asia.

Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study Across Asia.

Response to comment on "Pregnancy and perinatal outcomes of mothers with inflammatory bowel disease in Taiwan: A national database analysis".

Response to comment on "Pregnancy and perinatal outcomes of mothers with inflammatory bowel disease in Taiwan: A national database analysis".

Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity.

Role of leucine-rich α-2-glycoprotein in Taiwanese patients with inflammatory bowel disease as a predictive biomarker for endoscopic activity.

Temporal hospitalization trends for inflammatory bowel disease in Taiwan.

Temporal hospitalization trends for inflammatory bowel disease in Taiwan.

HLA-C*03:04:01 and HLA-B*15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.

HLA-C*03:04:01 and HLA-B*15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.

Fecal leukocyte esterase levels predict endoscopic severity as an alternative biomarker in inflammatory bowel disease.

Fecal leukocyte esterase levels predict endoscopic severity as an alternative biomarker in inflammatory bowel disease.

Demodicosis Mimics Acneiform Eruptions in Patients With Inflammatory Bowel Disease Receiving Upadacitinib.

Demodicosis Mimics Acneiform Eruptions in Patients With Inflammatory Bowel Disease Receiving Upadacitinib.

HLA-C03:04:01 and HLA-B15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.

HLA-C03:04:01 and HLA-B15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients.